136 related articles for article (PubMed ID: 29946371)
1. Clinical significance of heat shock proteins in gastric cancer following hyperthermia stress: Indications for hyperthermic intraperitoneal chemoperfusion therapy.
Tu Y; Tian Y; Wu Y; Cui S
Oncol Lett; 2018 Jun; 15(6):9385-9391. PubMed ID: 29946371
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia.
Pelz JO; Vetterlein M; Grimmig T; Kerscher AG; Moll E; Lazariotou M; Matthes N; Faber M; Germer CT; Waaga-Gasser AM; Gasser M
Ann Surg Oncol; 2013 Apr; 20(4):1105-13. PubMed ID: 23456378
[TBL] [Abstract][Full Text] [Related]
3. Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis.
Grimmig T; Moll EM; Kloos K; Thumm R; Moench R; Callies S; Kreckel J; Vetterlein M; Pelz J; Polat B; Tripathi S; Rehder R; Ribas CM; Chandraker A; Germer CT; Waaga-Gasser AM; Gasser M
Cancer Growth Metastasis; 2017; 10():1179064417730559. PubMed ID: 29403306
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.
Moukarzel LA; Ferrando L; Dopeso H; Stylianou A; Basili T; Pareja F; Da Cruz Paula A; Zoppoli G; Abu-Rustum NR; Reis-Filho JS; Long Roche K; Tew WP; Chi DS; Sonoda Y; Zamarin D; Aghajanian C; O'Cearbhaill RE; Zivanovic O; Weigelt B
Gynecol Oncol; 2022 May; 165(2):239-247. PubMed ID: 35292180
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study.
Tu Y; Tian Y; Fang Z; Ruan Q; Tang H; Zhang X; Wu Y; Ding Y; Cui S
Int J Hyperthermia; 2016 Sep; 32(6):587-94. PubMed ID: 27362668
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90.
Zunino B; Rubio-Patiño C; Villa E; Meynet O; Proics E; Cornille A; Pommier S; Mondragón L; Chiche J; Bereder JM; Carles M; Ricci JE
Oncogene; 2016 Jan; 35(2):261-8. PubMed ID: 25867070
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW
JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789
[TBL] [Abstract][Full Text] [Related]
8. Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model.
Bespalov VG; Kireeva GS; Belyaeva OA; Kalinin OE; Senchik KY; Stukov AN; Gafton GI; Guseynov KD; Belyaev AM
J Surg Oncol; 2016 Mar; 113(4):438-42. PubMed ID: 26710749
[TBL] [Abstract][Full Text] [Related]
9. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.
Zivanovic O; Abramian A; Kullmann M; Fuhrmann C; Coch C; Hoeller T; Ruehs H; Keyver-Paik MD; Rudlowski C; Weber S; Kiefer N; Poelcher ML; Thiesler T; Rostamzadeh B; Mallmann M; Schaefer N; Permantier M; Latten S; Kalff J; Thomale J; Jaehde U; Kuhn WC
Int J Cancer; 2015 Feb; 136(3):699-708. PubMed ID: 24895230
[TBL] [Abstract][Full Text] [Related]
10. Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Leijte GP; Custers H; Gerretsen J; Heijne A; Roth J; Vogl T; Scheffer GJ; Pickkers P; Kox M
Front Immunol; 2018; 9():663. PubMed ID: 29675023
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
12. Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.
Badgwell B; Blum M; Das P; Estrella J; Wang X; Ho L; Fournier K; Royal R; Mansfield P; Ajani J
Ann Surg Oncol; 2017 Oct; 24(11):3338-3344. PubMed ID: 28799004
[TBL] [Abstract][Full Text] [Related]
13. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
14. Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?
Lambert LA; Harris A
J Gastrointest Oncol; 2016 Feb; 7(1):112-21. PubMed ID: 26941989
[TBL] [Abstract][Full Text] [Related]
15. Cerebral edema in a patient following cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemoperfusion.
Nair RL; Tobias J; Stemmerman G; Lowy AM
World J Surg Oncol; 2006 Nov; 4():85. PubMed ID: 17137499
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites.
Lu C; Li L; Luo Z; Cui Y; Fu P; Zhou J; Ma N; Zhou Y
Neoplasma; 2016; 63(2):299-303. PubMed ID: 26774152
[TBL] [Abstract][Full Text] [Related]
17. Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.
Choudry HA; Bednar F; Shuai Y; Jones HL; Pai RK; Pingpank JF; Ahrendt SS; Holtzman MP; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2019 May; 26(5):1445-1453. PubMed ID: 30825033
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study.
Yarema RR; Ohorchak MA; Zubarev GP; Mylyan YP; Oliynyk YY; Zubarev MG; Gyrya PI; Kovalchuk YJ; Safiyan VI; Fetsych TG
Int J Hyperthermia; 2014 May; 30(3):159-65. PubMed ID: 24641798
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.
Magge D; Ramalingam L; Shuai Y; Edwards RP; Pingpank JF; Ahrendt SS; Holtzman MP; Zeh HJ; Bartlett DL; Choudry HA
J Surg Oncol; 2017 Sep; 116(3):320-328. PubMed ID: 28628712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]